Precision Oncology Market Report: Trends, Forecast and Competitive Analysis to 2030
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
1. EXECUTIVE SUMMARY
2. GLOBAL PRECISION ONCOLOGY MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Precision Oncology Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Precision Oncology Market by Product Type
3.3.1: Diagnostics
3.3.2: Therapeutics
3.4: Global Precision Oncology Market by Cancer Type
3.4.1: Breast Cancer
3.4.2: Cervical Cancer
3.4.3: Prostate Cancer
3.4.4: Lung Cancer
3.4.5: Others
3.5: Global Precision Oncology Market by End Use
3.5.1: Hospitals & Diagnostic Laboratories
3.5.2: Pharmaceutical & Biotechnology Companies
3.5.3: Healthcare Data Companies
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Precision Oncology Market by Region
4.2: North American Precision Oncology Market
4.2.2: North American Precision Oncology Market by End Use: Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies
4.3: European Precision Oncology Market
4.3.1: European Precision Oncology Market by Product Type: Diagnostics and Therapeutics
4.3.2: European Precision Oncology Market by End Use: Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies
4.4: APAC Precision Oncology Market
4.4.1: APAC Precision Oncology Market by Product Type: Diagnostics and Therapeutics
4.4.2: APAC Precision Oncology Market by End Use: Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies
4.5: ROW Precision Oncology Market
4.5.1: ROW Precision Oncology Market by Product Type: Diagnostics and Therapeutics
4.5.2: ROW Precision Oncology Market by End Use: Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Precision Oncology Market by Product Type
6.1.2: Growth Opportunities for the Global Precision Oncology Market by Cancer Type
6.1.3: Growth Opportunities for the Global Precision Oncology Market by End Use
6.1.4: Growth Opportunities for the Global Precision Oncology Market by Region
6.2: Emerging Trends in the Global Precision Oncology Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Precision Oncology Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Precision Oncology Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Thermo Fisher Scientific
7.2: Invitae
7.3: Qiagen
7.4: Illumina
7.5: Laboratory Corporation
7.6: Exact Sciences
7.7: Rain Oncology
7.8: Strata Oncology
7.9: Xilis
7.10: Variantyx
2. GLOBAL PRECISION ONCOLOGY MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Precision Oncology Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Precision Oncology Market by Product Type
3.3.1: Diagnostics
3.3.2: Therapeutics
3.4: Global Precision Oncology Market by Cancer Type
3.4.1: Breast Cancer
3.4.2: Cervical Cancer
3.4.3: Prostate Cancer
3.4.4: Lung Cancer
3.4.5: Others
3.5: Global Precision Oncology Market by End Use
3.5.1: Hospitals & Diagnostic Laboratories
3.5.2: Pharmaceutical & Biotechnology Companies
3.5.3: Healthcare Data Companies
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Precision Oncology Market by Region
4.2: North American Precision Oncology Market
4.2.2: North American Precision Oncology Market by End Use: Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies
4.3: European Precision Oncology Market
4.3.1: European Precision Oncology Market by Product Type: Diagnostics and Therapeutics
4.3.2: European Precision Oncology Market by End Use: Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies
4.4: APAC Precision Oncology Market
4.4.1: APAC Precision Oncology Market by Product Type: Diagnostics and Therapeutics
4.4.2: APAC Precision Oncology Market by End Use: Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies
4.5: ROW Precision Oncology Market
4.5.1: ROW Precision Oncology Market by Product Type: Diagnostics and Therapeutics
4.5.2: ROW Precision Oncology Market by End Use: Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, and Healthcare Data Companies
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Precision Oncology Market by Product Type
6.1.2: Growth Opportunities for the Global Precision Oncology Market by Cancer Type
6.1.3: Growth Opportunities for the Global Precision Oncology Market by End Use
6.1.4: Growth Opportunities for the Global Precision Oncology Market by Region
6.2: Emerging Trends in the Global Precision Oncology Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Precision Oncology Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Precision Oncology Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Thermo Fisher Scientific
7.2: Invitae
7.3: Qiagen
7.4: Illumina
7.5: Laboratory Corporation
7.6: Exact Sciences
7.7: Rain Oncology
7.8: Strata Oncology
7.9: Xilis
7.10: Variantyx
